Streptococcal Group A Infection
Symptoms, Doctors, Treatments, Advances & More

Streptococcal Group A Infection Overview

Save information for later
Sign Up

Learn About Streptococcal Group A Infection

What is the definition of Streptococcal Group A Infection?
Group A Streptococcus (strep) is a caused by a bacterium found in the throat and on the skin and is a potentially life-threatening disease. Two severe forms of invasive strep are 1) “the flesh-eating bacteria” (necrotizing fasciitis) and 2) Streptococcal Toxic Shock Syndrome (STSS). Both severe forms, however, are rare. Strep bacteria are spread through contact with infected persons or wounds. Necrotizing fasciitis can be caused by infected cuts, scrapes, burns, insect bites, puncture wounds, blunt trauma, and surgical wounds. While anyone can be infected with invasive strep, individuals with chronic diseases (cancer, diabetes, and chronic lung or heart disease), persons using steroid medications, individuals with skin lesions, and individuals living in residential communities (nursing homes, mental health facilities, and prisons, etc.) have a higher risk. In rare cases, invasive strep can cause pneumonia, organ failure, long-term heart problems, rapidly progressing life-threatening skin infection, and lead to amputations and death.
What are the symptoms of Streptococcal Group A Infection?
Symptoms of strep develop rapidly, within 12- 24 hours. Early symptoms can include high fever, severe muscle aches, severe pain, wound redness, dizziness, confusion, and widespread rash. Early symptoms of necrotizing fasciitis can include fever, red, warm, or swollen skin that spreads rapidly, and severe pain. Late symptoms of necrotizing fasciitis can include fatigue, dizziness, diarrhea, nausea, ulcers, blisters, black spots, skin color changes, and pus oozing from the wound.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Streptococcal Group A Infection?
The initial treatment for strep infection is antibiotics. The bacteria can be spread up until 24 hours after antibiotic treatment. If the infection becomes severe, rapidly developing into necrotizing fasciitis, intravenous (IV) antibiotics and surgery must also be administered rapidly to stop the disease from spreading. Surgeons must remove all the affected tissue, sometimes necessitating amputations and multiple surgeries. Patients are usually admitted to the intensive care unit (ICU). Blood transfusions may be also be necessary.
Who are the top Streptococcal Group A Infection Local Doctors?
Elite in Streptococcal Group A Infection
Andrew C. Steer
Elite in Streptococcal Group A Infection
Andrew C. Steer
Referral may be required
Flemington Road, 
Parkville, VIC, AU 

Andrew Steer practices practicing medicine in Parkville, Australia. Mr. Steer is rated as an Elite expert by MediFind in the treatment of Streptococcal Group A Infection. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Scabies, Impetigo, Strep Throat, and Streptococcal Group A Infection.

Elite in Streptococcal Group A Infection
Jose Cristino-Melo
Elite in Streptococcal Group A Infection
Jose Cristino-Melo
Referral may be required
Lisbon, PT 

Jose Cristino-Melo practices practicing medicine in Lisbon, Portugal. Mr. Cristino-Melo is rated as an Elite expert by MediFind in the treatment of Streptococcal Group A Infection. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Streptococcal Group A Infection, Strep Throat, Streptococcal Group B Infection, and Pneumonia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Streptococcal Group A Infection
Asha C. Bowen
Elite in Streptococcal Group A Infection
Asha C. Bowen
Referral may be required
32 Mouat St, 
Fremantle, WA, AU 

Asha Bowen practices practicing medicine in Fremantle, Australia. Ms. Bowen is rated as an Elite expert by MediFind in the treatment of Streptococcal Group A Infection. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Impetigo, Scabies, Streptococcal Group A Infection, and Strep Throat.

View All Doctors
What are the latest Streptococcal Group A Infection Clinical Trials?
A Prospective, Post-authorisation Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation, Including a Non-comparative Concurrent Reference Cohort
A Prospective, Post-authorisation Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation, Including a Non-comparative Concurrent Reference Cohort
Enrollment Status: Recruiting
Publish Date: April 24, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3

Summary: A prospective, post-authorisation long-term follow-up trial of patients previously treated with imlifidase prior to kidney transplantation, including a non-comparative concurrent reference cohort.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Single-arm, Multi-centre Trial to Evaluate Efficacy and Safety of Imlifidase in Highly Sensitised Children (1-17 Years) Receiving a Kidney Transplant With Positive Crossmatch Against a Living or Deceased Donor Converted to Negative After Imlifidase Treatment
A Single-arm, Multi-centre Trial to Evaluate Efficacy and Safety of Imlifidase in Highly Sensitised Children (1-17 Years) Receiving a Kidney Transplant With Positive Crossmatch Against a Living or Deceased Donor Converted to Negative After Imlifidase Treatment
Enrollment Status: Recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: The goal of this clinical trial is to learn about the efficacy and safety of imlifidase in highly sensitized paediatric patients, 1-17 years old, with end stage renal disease (ESRD). The main questions it aims to answer are: * Does imlifidase treatment result in crossmatch conversion that enables transplantation? * How is the function of the transplanted kidney? The participants will be hospitalis...

View All Clinical Trials